Brooks O'Neil
Stock Analyst at Lake Street
(0.68)
# 4,060
Out of 5,173 analysts
34
Total ratings
29.41%
Success rate
-19.47%
Average return
Main Sectors:
Stocks Rated by Brooks O'Neil
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDXG MiMedx Group | Maintains: Buy | $12 → $10 | $4.24 | +135.85% | 2 | Jan 20, 2026 | |
| LFMD LifeMD | Maintains: Buy | $14 → $8 | $3.98 | +101.01% | 4 | Nov 18, 2025 | |
| TNDM Tandem Diabetes Care | Downgrades: Hold | $75 → $12 | $25.09 | -52.17% | 2 | Aug 11, 2025 | |
| RCEL AVITA Medical | Maintains: Buy | $14 → $8 | $3.95 | +102.53% | 7 | Aug 11, 2025 | |
| PIII P3 Health Partners | Maintains: Buy | $50 → $20 | $3.03 | +560.07% | 2 | Apr 21, 2025 | |
| LMAT LeMaitre Vascular | Maintains: Buy | $105 → $110 | $107.86 | +1.98% | 2 | Feb 28, 2025 | |
| BBNX Beta Bionics | Initiates: Buy | $30 | $11.02 | +172.23% | 1 | Feb 24, 2025 | |
| LFVN LifeVantage | Initiates: Buy | $26 | $4.54 | +472.69% | 1 | Dec 19, 2024 | |
| HROW Harrow | Maintains: Buy | $45 → $55 | $34.00 | +61.76% | 3 | Oct 4, 2024 | |
| ATEC Alphatec Holdings | Maintains: Buy | $32 → $18 | $12.15 | +48.15% | 4 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $20 | $8.51 | +135.02% | 1 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $2.47 | +102.84% | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $26 | $24.49 | +6.17% | 2 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $0.18 | +6,086.73% | 1 | Apr 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $128 | $20.46 | +523.11% | 1 | Sep 15, 2020 |
MiMedx Group
Jan 20, 2026
Maintains: Buy
Price Target: $12 → $10
Current: $4.24
Upside: +135.85%
LifeMD
Nov 18, 2025
Maintains: Buy
Price Target: $14 → $8
Current: $3.98
Upside: +101.01%
Tandem Diabetes Care
Aug 11, 2025
Downgrades: Hold
Price Target: $75 → $12
Current: $25.09
Upside: -52.17%
AVITA Medical
Aug 11, 2025
Maintains: Buy
Price Target: $14 → $8
Current: $3.95
Upside: +102.53%
P3 Health Partners
Apr 21, 2025
Maintains: Buy
Price Target: $50 → $20
Current: $3.03
Upside: +560.07%
LeMaitre Vascular
Feb 28, 2025
Maintains: Buy
Price Target: $105 → $110
Current: $107.86
Upside: +1.98%
Beta Bionics
Feb 24, 2025
Initiates: Buy
Price Target: $30
Current: $11.02
Upside: +172.23%
LifeVantage
Dec 19, 2024
Initiates: Buy
Price Target: $26
Current: $4.54
Upside: +472.69%
Harrow
Oct 4, 2024
Maintains: Buy
Price Target: $45 → $55
Current: $34.00
Upside: +61.76%
Alphatec Holdings
Sep 3, 2024
Maintains: Buy
Price Target: $32 → $18
Current: $12.15
Upside: +48.15%
Aug 9, 2024
Maintains: Buy
Price Target: $15 → $20
Current: $8.51
Upside: +135.02%
Jun 28, 2024
Initiates: Buy
Price Target: $5
Current: $2.47
Upside: +102.84%
Feb 15, 2023
Maintains: Buy
Price Target: $20 → $26
Current: $24.49
Upside: +6.17%
Apr 8, 2022
Initiates: Buy
Price Target: $11
Current: $0.18
Upside: +6,086.73%
Sep 15, 2020
Initiates: Buy
Price Target: $128
Current: $20.46
Upside: +523.11%